Patients on mepolizumab, benralizumab, or dupilumab have diminished post-vaccination antibody and B cell responses to SARS-CoV-2.
Year: 2023
Type: conference-abstract
Authors: Pedro Lamothe, Martin Runnstrom, Katia Faliti, Narayanaiah Cheedrala, Alberto Moreno, Mehul Suthar, Rishika Nahata, Mayuran Ravindran, Andrea Morrison-Porter, Richard Ramonell, Matthew Woodruff, Robert Swerlick, Colin Swenson, Carmen Polito, Wendy Neveu, Natalia Smirnova, Caroline Kim, Ian Hentenaar, Shuya Kyu, Zhenxing Guo, Hao Wu, Natalie Haddad, Jiwon Park, John Daiss, Suneetha Cheedarla, Andrew Neish, John Roback, Sunita Sharma, Fernando Holguin, Ignacio Sanz, Frances Eun-Hyung Lee
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4387982103